Abstract
To explore whether DNA methylation of the ATP-binding cassette G1 (ABCG1) gene and its dynamic change are associated with incident type 2 diabetes mellitus (T2DM). We conducted a nested case–control study with 286 pairs of T2DM cases and matched controls nested in the Rural Chinese Cohort Study. Conditional logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for incident T2DM risk according to ABCG1 methylation level at baseline and its dynamic change at follow-up examination. Spearman’s rank correlation coefficients were used to analyze the association between ABCG1 methylation and its possible risk factors in the control group. We found that T2DM risk increased by 16% (OR = 1.16, 95% CI = 1.02–1.31) with each 1% increase in DNA methylation levels of the ABCG1 loci CpG13 and CpG14. DNA methylation change of the ABCG1 locus CpG15 during the 6-year follow-up was associated with increased T2DM risk: T2DM risk increased by 78% in the upper tertile group (methylation gain ≥5%) versus lower tertile group (methylation gain <1%) (OR = 1.78, 95% CI = 1.01–3.15). Furthermore, body mass index was positively correlated with the DNA methylation level of the ABCG1 loci CpG13, CpG14 and CpG15. In conclusion, DNA methylation levels of the ABCG1 loci CpG13 and CpG14 and the methylation gain of locus CpG15 were positively associated with incident T2DM risk, which may suggest a possible etiologic pattern for T2DM and potentially improve T2DM prediction in rural Chinese people.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14:88–98.
International Diabetes Federation. IDF Diabetes Atlas, 9th edn. https://diabetesatlas.org.
Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444:840–6.
Rawshani A, Rawshani A, Gudbjörnsdottir S. Smoking and other risk factors in type 2 diabetes. N Engl J Med. 2018;379:2575.
Knott C, Bell S, Britton A. Alcohol consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of more than 1.9 million individuals from 38 observational studies. Diabetes Care. 2015;38:1804–12.
Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003;33:245–54.
Lawlor N, Khetan S, Ucar D, Stitzel ML. Genomics of islet (Dys)function and type 2 diabetes. Trends Genet. 2017;33:244–55.
Pfeiffer L, Wahl S, Pilling LC, Reischl E, Sandling JK, Kunze S, et al. DNA methylation of lipid-related genes affects blood lipid levels. Circ Cardiovasc Genet. 2015;8:334–42.
Chambers JC, Loh M, Lehne B, Drong A, Kriebel J, Motta V, et al. Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study. Lancet Diabetes Endocrinol. 2015;3:526–34.
Matsuo M. ATP-binding cassette proteins involved in glucose and lipid homeostasis. J Agric Chem Soc Jpn. 2010;74:899–907.
Kennedy MA, Barrera GC, Nakamura K, Baldán A, Tarr P, Fishbein MC, et al. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metabol. 2005;1:121–31.
Tarling EJ. Expanding roles of ABCG1 and sterol transport. Current Opin Lipidol. 2013;24:138–46.
SJCM Frambach, Rd Haas, JAM Smeitink, Rongen GA, FGM Russel, TJJ Schirris. Brothers in arms: ABCA1- and ABCG1-mediated cholesterol efflux as promising targets in cardiovascular disease treatment. Pharmacol Rev. 2020;72:152–90.
Kriebel J, Herder C, Rathmann W, Wahl S, Kunze S, Molnos S, et al. Association between DNA methylation in whole blood and measures of glucose metabolism: KORA F4 study. PLoS One. 2016;11:e0152314.
Krause C, Sievert H, Geißler C, Grohs M, Gammal ATE, Wolter S, et al. Critical evaluation of the DNA-methylation markers ABCG1 and SREBF1 for Type 2 diabetes stratification. Epigenomics. 2019;11:885–97.
Walaszczyk E, Luijten M, Spijkerman AMW, Bonder MJ, Lutgers HL, Snieder H, et al. DNA methylation markers associated with type 2 diabetes, fasting glucose and HbA1c levels: a systematic review and replication in a case-control sample of the Lifelines study. Diabetologia. 2018;61:354–68.
Dayeh T, Tuomi T, Almgren P, Perfilyev A, Jansson P-A, Mello VDd, et al. DNA methylation of loci within ABCG1 and PHOSPHO1 in blood DNA is associated with future type 2 diabetes risk. Epigenetics. 2016;11:482–8.
Hidalgo B, Irvin MR, Sha J, Zhi D, Aslibekyan S, Absher D, et al. Epigenome-wide association study of fasting measures of glucose, insulin, and HOMA-IR in the Genetics of Lipid Lowering Drugs and Diet Network study. Diabetes. 2014;63:801–7.
Cardona A, Day FR, Perry JRB, Loh M, Chu AY, Lehne B, et al. Epigenome-Wide Association Study of Incident Type 2 Diabetes in a British Population: EPIC-Norfolk Study. Diabetes. 2019;68:2315–26.
Kulkarni H, Kos MZ, Neary J, Dyer TD, JWK Jr, HHH Göring, et al. Novel epigenetic determinants of type 2 diabetes in Mexican-American families. Human Mol Genet. 2015;24:5330–44.
Peng P, Wang L, Yang X, Huang X, Ba Y, Chen X, et al. A preliminary study of the relationship between promoter methylation of the ABCG1, GALNT2 and HMGCR genes and coronary heart disease. PLoS One. 2014;9:e102265.
Martin EM, Fry RC. Environmental influences on the epigenome: exposure- associated DNA methylation in human populations. Ann Rev Public Health. 2018;39:309–33.
Zhao Y, Zhang M, Luo X, Wang C, Li L, Zhang L, et al. Association of 6-year waist circumference gain and incident hypertension. Heart. 2017;103:1347–52.
Zhang M, Zhao Y, Sun H, Luo X, Wang C, Li L, et al. Effect of dynamic change in body mass index on the risk of hypertension: Results from the Rural Chinese Cohort Study. Int J Cardiol. 2017;238:117–22.
Tomar SL, Asma S. Smoking-attributable periodontitis in the United States: findings from NHANES III. National Health and Nutrition Examination Survey. J Periodontol. 2000;71:743–51.
Zhang M, Wang B, Liu Y, Sun X, Luo X, Wang C, et al. Cumulative increased risk of incident type 2 diabetes mellitus with increasing triglyceride glucose index in normal-weight people: the Rural Chinese Cohort Study. Cardiovasc Diabetol. 2017;16:30.
Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exercise. 2003;35:1381–95.
Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense H-W, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289:2363–9.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.
Jia W, Weng J, Zhu D, Ji L, Lu J, Zhou Z, et al. Standards of medical care for type 2 diabetes in China 2019. Diabetes/Metabol Res Rev. 2019;35:e3158.
Zhang D, Cheng C, Cao M, Wang T, Chen X, Zhao Y, et al. TXNIP hypomethylation and its interaction with obesity and hypertriglyceridemia increase type 2 diabetes mellitus risk: a nested case-control study. J Diabetes. 2020;9:1753–0407.
Yvan-Charvet L, Nan Wang ART. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler Thromb Vasc Biol. 2009;30:139–43.
Kruit JK, Wijesekara N, Westwell-Roper C, Vanmierlo T, Haan Wd, Bhattacharjee A, et al. Loss of both ABCA1 and ABCG1 results in increased disturbances in islet sterol homeostasis, inflammation, and impaired beta-cell function. Diabetes. 2012;61:659–64.
Parrillo L, Spinelli R, Nicolò A, Longo M, Mirra P, Raciti GA, et al. Nutritional factors, DNA methylation, and risk of type 2 diabetes and obesity: perspectives and challenges. Int J Mol Sci. 2019;20:2983.
Ling C, Groop L. Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes. 2009;58:2718–25.
Dekkers KF, Iterson Mv, Slieke RC, Moed MH, Bonder MJ, Galen Mv, et al. Blood lipids influence DNA methylation in circulating cells. Genome Biol. 2016;17:138.
Pfeiffer L, Wahl S, Pilling LC, Reischl E, Sandling JK, Kunze S, et al. DNA methylation of lipid-related genes affects blood lipid levels. Circ Cardiovasc Genet. 2015;8:334–42.
Wahl S, Drong A, Lehne B, Loh M, Scott WR, Kunze S, et al. Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity. Nature. 2017;541:81–6.
Ling C. Epigenetic regulation of insulin action and secretion - role in the pathogenesis of type 2 diabetes. J Internal Med. 2020;288:158–67.
Voisin S, Eynon N, Yan X, Bishop DJ. Exercise training and DNA methylation in humans. Acta Physiol. 2015;213:39–59.
Rönn T, Volkov P, Davegårdh C, Dayeh T, Hall E, Olsson AH, et al. A six months exercise intervention influences the genome-wide DNA methylation pattern in human adipose tissue. PLoS Genet. 2013;9:e1003572.
Nitert MD, Dayeh T, Volkov P, Elgzyri T, Hall E, Nilsson E, et al. Impact of an exercise intervention on DNA methylation in skeletal muscle from first-degree relatives of patients with type 2 diabetes. Diabetes. 2012;61:3322–32.
Perfilyev A, Dahlman I. Impact of polyunsaturated and saturated fat overfeeding on the DNA-methylation pattern in human adipose tissue: a randomized controlled trial. Am J Clin Nutr. 2017;105:991–1000.
Gillberg L, Rönn T, Jørgensen SW, Perfilyev A, Hjort L, Nilsson E, et al. Fasting unmasks differential fat and muscle transcriptional regulation of metabolic gene sets in low versus normal birth weight men. EBioMedicine. 2019;47:341–51.
Hjort L, Jørgensen SW, Gillberg L, Hall E, Brøns C, Frystyk J, et al. 36 h fasting of young men influences adipose tissue DNA methylation of LEP and ADIPOQ in a birth weight-dependent manner. Clin Epigenetics. 2017;9:40.
Acknowledgements
This study was supported by the National Natural Science Foundation of China (Grant nos. 81402752 and 81673260); the Natural Science Foundation of Guangdong Province (Grant no 2019A1515011183); and the Science and Technology Development Foundation of Shenzhen (Grant nos. JCYJ20170412110537191 and JCYJ20190808145805515). The investigators are grateful to the dedicated participants and all research staff of the study.
Author information
Authors and Affiliations
Contributions
RQ, DH, and MZ substantially contributed to the design and drafting of the study and the analysis and interpretation of the data. QC, TW, XC, JW, RC, JL, YZ, DL, PQ, CC, LL, QL, CG, QZ, GT, MH, SH, YZ, XW, YW, YL, XY, YZ, YF, DH, and MZ revised it critically for important intellectual content. All authors were involved in the collection of data and approval of the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Qie, R., Chen, Q., Wang, T. et al. Association of ABCG1 gene methylation and its dynamic change status with incident type 2 diabetes mellitus: the Rural Chinese Cohort Study. J Hum Genet 66, 347–357 (2021). https://doi.org/10.1038/s10038-020-00848-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s10038-020-00848-z
This article is cited by
-
DNA methylation risk score for type 2 diabetes is associated with gestational diabetes
Cardiovascular Diabetology (2024)
-
Metabolic memory: mechanisms and diseases
Signal Transduction and Targeted Therapy (2024)
-
Hypomethylation of ABCG1 in peripheral blood as a potential marker for the detection of coronary heart disease
Clinical Epigenetics (2023)
-
Epigenetics of type 2 diabetes mellitus and weight change — a tool for precision medicine?
Nature Reviews Endocrinology (2022)
-
Uncurtaining the pivotal role of ABC transporters in diabetes mellitus
Environmental Science and Pollution Research (2021)